BioStock: Market update Chordate Medical – “We have a favourable position”

Chordate Medical’s nerve stimulating treatment is currently being introduced in several markets around Europe as well as in Israel and Saudi Arabia. The company is working with marketing and sales activities to achieve measurable market shares for a future exit. BioStock reached out the company’s CEO Anders Weilandt to get an update.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/04/market-update-chordate-medical-we-have-a-favourable-position/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se